Iohexol
-
Iohexol
structure -
-
CAS No:
66108-95-0
-
Formula:
C19H26I3N3O9
-
Chemical Name:
Iohexol
-
Synonyms:
1,3-Benzenedicarboxamide,5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-;1,3-Benzenedicarboxamide,5-[acetyl(2,3-dihydroxypropyl)amino]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-;5-[Acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide;Iohexol;Exypaque;Nycodenz;Omnipaque;Omnipaque 240;Omnipaque 140;Omnipaque 350;Omnipaque 300;Omnipaque R;Accudenz;5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl)isophthalamide.;Histodenz;Accupaque 300;Iopaque 240;Iopaque 300;Ioverin 350;1445001-72-8
- Categories:
-
CAS No:
Description
Iohexol is a contrast agent.Target: OthersIohexol is a contrast agent. The osmolality of iohexol ranges from 322 mOsm/kg-approximately 1.1 times that of blood plasma-to 844 mOsm/kg, almost three times that of blood. Despite this difference, iohexol is still considered a low-osmolality contrast agent; the osmolality of older agents, such as diatrizoate, may be more than twice as high. From Wikipedia.
Solid
Iohexol is a benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic. It is an organoiodine compound and a benzenedicarboxamide.|Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.|Iohexol is a Radiographic Contrast Agent. The mechanism of action of iohexol is as a X-Ray Contrast Activity.|Iohexol is an X-ray contrast medium containing iohexol in various concentrations, from 140 to 350 milligrams of iodine per milliliter.|An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
Iohexol Basic Attributes
821.14
821.14
266-164-2
4419T9MX03
DTXSID6023157
C65939
V08AB02|V - Various
2924299090
Characteristics
200
-3
Solid
2.2±0.1 g/cm3
174-180 °C
891.5°C at 760 mmHg
493.0±34.3 °C
1.724
7.96e-01 g/L
−20°C
LD50 in male, female rats, mice (g Iodine/kg): 15.0, 12.3, 24.3, 25.1 i.v. (Salvesen)
Safety Information
NONH for all modes of transport
1
22-24/25
CZ2205000
P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362
H315
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|Aggregated GHS information provided by 3 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
Non-ionic radiocontrast agents like iohexol are cytotoxic to renal cells. The toxic effects include apoptosis, cellular energy failure, disruption of calcium homeostasis, and disturbance of tubular cell polarity, and are thought to be linked to oxidative stress.
Drug Information
Iohexol ia used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures.
Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
Small amounts are absorbed through the bladder via intravesical instillation. Following intrauterine instillation, the majority of the medium within the uterine cavity is discharged into the vagina immediately upon termination of procedure. However, any medium retained in the uterine or peritoneal cavity is absorbed systemically within 60 minutes. May not be absorbed for up to 24 hours if tubes are obstructed and dilated.|Iohexol is absorbed from cerebrospinal fluid (CSF) into the bloodstream and is eliminated by renal excretion. No significant metabolism, deiodination, or biotransformation occurs.|350-849 mL/kg|109 mL/min [Adult patients receiving 16-18 ml of iohexol (180 mgI/mL) by lumbar intrathecal injection]
Intrathecal half-life is 3.4 hours (mean). Intravascular is approximately 2 hours (with normal renal function).
Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. After intrathecal administration into the subarachnoid space, diffusion of iohexol in the CSF allows the visualization of the subarachnoid spaces of the head and spinal canal. After intravascular administration, iohexol makes opaque those vessels in its path of flow, allowing visualization of the internal structures until significant hemodilution occurs.
Compound 545
Iohexol Use and Manufacturing
Compound A (1120.5 kg, 1.50 kmol) was dissolved in a solution of KOH (140.0 kg, 2.25 kmol) in water (1232.6 kg), the temperature was controlled to below 20°C, boric acid (64.9 kg, 1.05 kmol) was equally added in a batch manner, and hydrochloric acid (30.4 kg, 0.30 kmol) was added dropwise, followed by epichlorohydrin (83.3 kg, 0.90 kmol), which was added dropwise. The pH during the reaction is 10-11. The reaction was monitored and a sample was analyzed by HPLC. The reaction was quenched by adding water (1232.6 kg) and adjusting the pH to within the range 5-6 with 18percent of hydrochloric acid when the content of Compound A was below 5percent.The reaction mixture was then decolorized with active charcoal and filtered. The filtrate contained 86.3percent of iodixanol, 7.5percent of iohexol, 2.9percent of compound A and 2.7percent of O-alkylated by-products and other impurities by HPLC analysis.Example 3 5-acetylamino-N, N'-bis (2, 3-dihydroxypropyl)-2, 4, 6-triiodoisophthalamide (Compound A) (201.5 g, 0.268 mole) was dissolved in a solution of methanol (200 mL, 1.00 mL/g Compound A) and sodium hydroxide (13.92 g, 0.348 mole, 1.30 eq) at 45°C. The mixture was cooled to 20°C and conc. hydrochloric acid (17 mL, 0.204 mole, 0.76 eq) was added followed by epichlorohydrin (8.92 g, 0.096 mole, 0.36 eq) added in one portion. After 48 hours an HPLC analysis showed the following composition: 52.1 percent iodixanol, 36.2 percent Compound A, 1.42 percent backpeaks, 0.20 percent N-acetyl cyclized iodixanol, 7.42 percent iohexol and 2.06 percent iopentol.Sodium hydroxide pellets (1.19 eq.) was dissolved in water (250 ml) and 5-acetamido-N, N'-bis(2, 3-dihydroxypropyl)-2, 4, 6-triiodo-isophthalamide (Compound A) (50 g) was added. pH was adjusted with 2 M hydrochloric acid from 12.7 to 12.2 and the mixture was cooled to 20°C followed by addition of epichlorohydrin (0.27 eq) added in three portions over 70 minutes. After 48 hours an HPLC analysis showed the following composition: 43.5 percent iodixanol, 0.8 percent backpeaks and 5.1 percent iohexol.
antibacterial
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:821.1
XLogP3:-3
Hydrogen Bond Donor Count:8
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:12
Exact Mass:820.8803
Monoisotopic Mass:820.8803
Topological Polar Surface Area:200
Heavy Atom Count:34
Complexity:653
Undefined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is a commonly used contrast agent for X-ray and CT examinations, and can be used in blood vessels, spinal canals, and body cavities. Animal test results show that this product has an enhancement effect on dog liver, abdominal aorta, and CT scan images.
Registered Holders
-
DIVI'S LABOTATORIES LTD
Active
United States
-
Zhejiang Haizhou Pharmaceutical Co., Ltd.
Active
China
-
Zhejiang Hichi Pharmaceutical Corporation Limited
Active
China
Recommended Suppliers of Iohexol
-
CN
3 YRS
Business licensedTrader Supplier of chemical -
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
3 YRS
Business licensedTrader Supplier of CHEMICALS,REAGENTSInquiryCAS No.: 66108-95-0Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of Eltrombopeg,Gadobutrol,Saxagliptin,Obeticholic,Baricitinib -
CN
3 YRS
Business licensed Certified factoryManufactory Supplier of Gadoterate Meglumine,Gadoteridol,Gadobutrol,Iopamidol,iohexol,Ioversol,Ganciclovir sodium,Aciclovir sodium
Learn More Other Chemicals
-
7-Azabicyclo[2.2.1]heptane-1-carboxamide,N-methyl-(9CI)
783298-25-9
-
1(10)-Aristolen-2-one
28398-06-3
-
3'-AZIDO-2'-3'-DIDEOXYGUANOSINE
66323-46-4
-
Azirino[1,2-b]isoxazolo[4,5-d]pyridazine, 3a,7,7a,7b-tetrahydro- (9CI) Formula
444723-81-3
-
17BETA-ESTRADIOL-16,16-D2 Formula
3188-46-3
-
Tetrahydropyranylphytol Formula
66432-63-1
-
Cyanic acid, C,C′-[(1-methylethylidene)di-4,1-phenylene] ester, homopolymer Structure
25722-66-1
-
17β-Hydroxyestra-4,9-dien-3-one Structure
6218-29-7
-
What is dichlorocopper,2-piperidin-1-id-2-ylpiperidin-1-ide
22393-36-8
-
What is dialuminiumtricalciumhexaoxide
12042-78-3